Standard Biotools | FLDM - Current Assets


Standard Biotools reported $497.3M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Bio-Rad Laboratories USD 3.08B 58.1M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Illumina USD 3.04B 201M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Nikon Corporation JPY 658.9B 7.17B Sep/2026
Pacific Biosciences Of California USD 307.85M 30.78M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sony JPY 6.36T 240.89B Sep/2026
Standard Biotools USD 497.3M 19.56M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Waters USD 3.9B 186M Jun/2026